Panacea Biotec Ltd (NSE:PANACEABIO) Share Price

Company Profile

Business description
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.
Contact
Mathura Road, B-1 Extension/G-3
Mohan Co-operative Industrial Estate
New Delhi110 044
IND
T: +91 1141679000
https://www.panaceabiotec.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2025
Employees
1,302

Recommended

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Matt Wacher | 21 February 2025

We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.

Lochlan Halloway | 20 February 2025

Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.

Joseph Taylor | 20 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,570.90	30.80	-0.36%
CAC 40	8,154.51	31.93	0.39%
DAX 40	22,287.56	27.09	-0.12%
Dow JONES (US)	43,725.89	450.76	-1.02%
FTSE 100	8,659.37	3.60	-0.04%
HKSE	23,477.92	900.94	3.99%
NASDAQ	19,764.02	198.34	-0.99%
Nikkei 225	38,776.94	98.90	0.26%
NZX 50 Index	12,752.58	127.78	-0.99%
S&P 500	6,071.32	46.20	-0.76%
S&P/ASX 200	8,296.20	26.60	-0.32%
SSE Composite Index	3,379.11	28.33	0.85%